1 Nucleic Acid Vaccine Market Overview
1.1 Product Overview and Scope of Nucleic Acid Vaccine
1.2 Nucleic Acid Vaccine Segment by Type
1.2.1 Global Nucleic Acid Vaccine Market Value Comparison by Type (2023-2029)
1.2.2 Preventive Nucleic Acid Vaccine
1.2.3 Therapeutic Vucleic Acid Vaccine
1.3 Nucleic Acid Vaccine Segment by Application
1.3.1 Global Nucleic Acid Vaccine Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Nucleic Acid Vaccine Market Size Estimates and Forecasts
1.4.1 Global Nucleic Acid Vaccine Revenue 2018-2029
1.4.2 Global Nucleic Acid Vaccine Sales 2018-2029
1.4.3 Global Nucleic Acid Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Nucleic Acid Vaccine Market Competition by Manufacturers
2.1 Global Nucleic Acid Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Nucleic Acid Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Nucleic Acid Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global Nucleic Acid Vaccine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Nucleic Acid Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nucleic Acid Vaccine, Product Type & Application
2.7 Nucleic Acid Vaccine Market Competitive Situation and Trends
2.7.1 Nucleic Acid Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nucleic Acid Vaccine Players Market Share by Revenue
2.7.3 Global Nucleic Acid Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nucleic Acid Vaccine Retrospective Market Scenario by Region
3.1 Global Nucleic Acid Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Nucleic Acid Vaccine Global Nucleic Acid Vaccine Sales by Region: 2018-2029
3.2.1 Global Nucleic Acid Vaccine Sales by Region: 2018-2023
3.2.2 Global Nucleic Acid Vaccine Sales by Region: 2024-2029
3.3 Global Nucleic Acid Vaccine Global Nucleic Acid Vaccine Revenue by Region: 2018-2029
3.3.1 Global Nucleic Acid Vaccine Revenue by Region: 2018-2023
3.3.2 Global Nucleic Acid Vaccine Revenue by Region: 2024-2029
3.4 North America Nucleic Acid Vaccine Market Facts & Figures by Country
3.4.1 North America Nucleic Acid Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Nucleic Acid Vaccine Sales by Country (2018-2029)
3.4.3 North America Nucleic Acid Vaccine Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Nucleic Acid Vaccine Market Facts & Figures by Country
3.5.1 Europe Nucleic Acid Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Nucleic Acid Vaccine Sales by Country (2018-2029)
3.5.3 Europe Nucleic Acid Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nucleic Acid Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Nucleic Acid Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Nucleic Acid Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Nucleic Acid Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Nucleic Acid Vaccine Market Facts & Figures by Country
3.7.1 Latin America Nucleic Acid Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Nucleic Acid Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Nucleic Acid Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nucleic Acid Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Nucleic Acid Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Nucleic Acid Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Nucleic Acid Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nucleic Acid Vaccine Sales by Type (2018-2029)
4.1.1 Global Nucleic Acid Vaccine Sales by Type (2018-2023)
4.1.2 Global Nucleic Acid Vaccine Sales by Type (2024-2029)
4.1.3 Global Nucleic Acid Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Nucleic Acid Vaccine Revenue by Type (2018-2029)
4.2.1 Global Nucleic Acid Vaccine Revenue by Type (2018-2023)
4.2.2 Global Nucleic Acid Vaccine Revenue by Type (2024-2029)
4.2.3 Global Nucleic Acid Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Nucleic Acid Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Nucleic Acid Vaccine Sales by Application (2018-2029)
5.1.1 Global Nucleic Acid Vaccine Sales by Application (2018-2023)
5.1.2 Global Nucleic Acid Vaccine Sales by Application (2024-2029)
5.1.3 Global Nucleic Acid Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Nucleic Acid Vaccine Revenue by Application (2018-2029)
5.2.1 Global Nucleic Acid Vaccine Revenue by Application (2018-2023)
5.2.2 Global Nucleic Acid Vaccine Revenue by Application (2024-2029)
5.2.3 Global Nucleic Acid Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Nucleic Acid Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Moderna
6.1.1 Moderna Corporation Information
6.1.2 Moderna Description and Business Overview
6.1.3 Moderna Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Moderna Nucleic Acid Vaccine Product Portfolio
6.1.5 Moderna Recent Developments/Updates
6.2 CureVac
6.2.1 CureVac Corporation Information
6.2.2 CureVac Description and Business Overview
6.2.3 CureVac Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 CureVac Nucleic Acid Vaccine Product Portfolio
6.2.5 CureVac Recent Developments/Updates
6.3 Inovio
6.3.1 Inovio Corporation Information
6.3.2 Inovio Description and Business Overview
6.3.3 Inovio Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Inovio Nucleic Acid Vaccine Product Portfolio
6.3.5 Inovio Recent Developments/Updates
6.4 Sanofi
6.4.1 Sanofi Corporation Information
6.4.2 Sanofi Description and Business Overview
6.4.3 Sanofi Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sanofi Nucleic Acid Vaccine Product Portfolio
6.4.5 Sanofi Recent Developments/Updates
6.5 GSK
6.5.1 GSK Corporation Information
6.5.2 GSK Description and Business Overview
6.5.3 GSK Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 GSK Nucleic Acid Vaccine Product Portfolio
6.5.5 GSK Recent Developments/Updates
6.6 CNBG
6.6.1 CNBG Corporation Information
6.6.2 CNBG Description and Business Overview
6.6.3 CNBG Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 CNBG Nucleic Acid Vaccine Product Portfolio
6.6.5 CNBG Recent Developments/Updates
6.7 Hualan Bio
6.6.1 Hualan Bio Corporation Information
6.6.2 Hualan Bio Description and Business Overview
6.6.3 Hualan Bio Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Hualan Bio Nucleic Acid Vaccine Product Portfolio
6.7.5 Hualan Bio Recent Developments/Updates
6.8 Zhifei Shengwu
6.8.1 Zhifei Shengwu Corporation Information
6.8.2 Zhifei Shengwu Description and Business Overview
6.8.3 Zhifei Shengwu Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Zhifei Shengwu Nucleic Acid Vaccine Product Portfolio
6.8.5 Zhifei Shengwu Recent Developments/Updates
6.9 Liaoning Chengda
6.9.1 Liaoning Chengda Corporation Information
6.9.2 Liaoning Chengda Description and Business Overview
6.9.3 Liaoning Chengda Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Liaoning Chengda Nucleic Acid Vaccine Product Portfolio
6.9.5 Liaoning Chengda Recent Developments/Updates
6.10 BioKangtai
6.10.1 BioKangtai Corporation Information
6.10.2 BioKangtai Description and Business Overview
6.10.3 BioKangtai Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.10.4 BioKangtai Nucleic Acid Vaccine Product Portfolio
6.10.5 BioKangtai Recent Developments/Updates
6.11 CanSinoBIO
6.11.1 CanSinoBIO Corporation Information
6.11.2 CanSinoBIO Nucleic Acid Vaccine Description and Business Overview
6.11.3 CanSinoBIO Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.11.4 CanSinoBIO Nucleic Acid Vaccine Product Portfolio
6.11.5 CanSinoBIO Recent Developments/Updates
6.12 Walvax Biotechnology
6.12.1 Walvax Biotechnology Corporation Information
6.12.2 Walvax Biotechnology Nucleic Acid Vaccine Description and Business Overview
6.12.3 Walvax Biotechnology Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Walvax Biotechnology Nucleic Acid Vaccine Product Portfolio
6.12.5 Walvax Biotechnology Recent Developments/Updates
6.13 Fosun Pharma
6.13.1 Fosun Pharma Corporation Information
6.13.2 Fosun Pharma Nucleic Acid Vaccine Description and Business Overview
6.13.3 Fosun Pharma Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Fosun Pharma Nucleic Acid Vaccine Product Portfolio
6.13.5 Fosun Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nucleic Acid Vaccine Industry Chain Analysis
7.2 Nucleic Acid Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nucleic Acid Vaccine Production Mode & Process
7.4 Nucleic Acid Vaccine Sales and Marketing
7.4.1 Nucleic Acid Vaccine Sales Channels
7.4.2 Nucleic Acid Vaccine Distributors
7.5 Nucleic Acid Vaccine Customers
8 Nucleic Acid Vaccine Market Dynamics
8.1 Nucleic Acid Vaccine Industry Trends
8.2 Nucleic Acid Vaccine Market Drivers
8.3 Nucleic Acid Vaccine Market Challenges
8.4 Nucleic Acid Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Nucleic Acid Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Nucleic Acid Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Nucleic Acid Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Nucleic Acid Vaccine Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Nucleic Acid Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Nucleic Acid Vaccine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Nucleic Acid Vaccine Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Nucleic Acid Vaccine Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Nucleic Acid Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Nucleic Acid Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Nucleic Acid Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Nucleic Acid Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Nucleic Acid Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Nucleic Acid Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Nucleic Acid Vaccine Sales by Region (2018-2023) & (K Units)
Table 18. Global Nucleic Acid Vaccine Sales Market Share by Region (2018-2023)
Table 19. Global Nucleic Acid Vaccine Sales by Region (2024-2029) & (K Units)
Table 20. Global Nucleic Acid Vaccine Sales Market Share by Region (2024-2029)
Table 21. Global Nucleic Acid Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Nucleic Acid Vaccine Revenue Market Share by Region (2018-2023)
Table 23. Global Nucleic Acid Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Nucleic Acid Vaccine Revenue Market Share by Region (2024-2029)
Table 25. North America Nucleic Acid Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Nucleic Acid Vaccine Sales by Country (2018-2023) & (K Units)
Table 27. North America Nucleic Acid Vaccine Sales by Country (2024-2029) & (K Units)
Table 28. North America Nucleic Acid Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Nucleic Acid Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Nucleic Acid Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Nucleic Acid Vaccine Sales by Country (2018-2023) & (K Units)
Table 32. Europe Nucleic Acid Vaccine Sales by Country (2024-2029) & (K Units)
Table 33. Europe Nucleic Acid Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Nucleic Acid Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Nucleic Acid Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Nucleic Acid Vaccine Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Nucleic Acid Vaccine Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Nucleic Acid Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Nucleic Acid Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Nucleic Acid Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Nucleic Acid Vaccine Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Nucleic Acid Vaccine Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Nucleic Acid Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Nucleic Acid Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Nucleic Acid Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Nucleic Acid Vaccine Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Nucleic Acid Vaccine Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Nucleic Acid Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Nucleic Acid Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Nucleic Acid Vaccine Sales (K Units) by Type (2018-2023)
Table 51. Global Nucleic Acid Vaccine Sales (K Units) by Type (2024-2029)
Table 52. Global Nucleic Acid Vaccine Sales Market Share by Type (2018-2023)
Table 53. Global Nucleic Acid Vaccine Sales Market Share by Type (2024-2029)
Table 54. Global Nucleic Acid Vaccine Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Nucleic Acid Vaccine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Nucleic Acid Vaccine Revenue Market Share by Type (2018-2023)
Table 57. Global Nucleic Acid Vaccine Revenue Market Share by Type (2024-2029)
Table 58. Global Nucleic Acid Vaccine Price (US$/Unit) by Type (2018-2023)
Table 59. Global Nucleic Acid Vaccine Price (US$/Unit) by Type (2024-2029)
Table 60. Global Nucleic Acid Vaccine Sales (K Units) by Application (2018-2023)
Table 61. Global Nucleic Acid Vaccine Sales (K Units) by Application (2024-2029)
Table 62. Global Nucleic Acid Vaccine Sales Market Share by Application (2018-2023)
Table 63. Global Nucleic Acid Vaccine Sales Market Share by Application (2024-2029)
Table 64. Global Nucleic Acid Vaccine Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Nucleic Acid Vaccine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Nucleic Acid Vaccine Revenue Market Share by Application (2018-2023)
Table 67. Global Nucleic Acid Vaccine Revenue Market Share by Application (2024-2029)
Table 68. Global Nucleic Acid Vaccine Price (US$/Unit) by Application (2018-2023)
Table 69. Global Nucleic Acid Vaccine Price (US$/Unit) by Application (2024-2029)
Table 70. Moderna Corporation Information
Table 71. Moderna Description and Business Overview
Table 72. Moderna Nucleic Acid Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Moderna Nucleic Acid Vaccine Product
Table 74. Moderna Recent Developments/Updates
Table 75. CureVac Corporation Information
Table 76. CureVac Description and Business Overview
Table 77. CureVac Nucleic Acid Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. CureVac Nucleic Acid Vaccine Product
Table 79. CureVac Recent Developments/Updates
Table 80. Inovio Corporation Information
Table 81. Inovio Description and Business Overview
Table 82. Inovio Nucleic Acid Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Inovio Nucleic Acid Vaccine Product
Table 84. Inovio Recent Developments/Updates
Table 85. Sanofi Corporation Information
Table 86. Sanofi Description and Business Overview
Table 87. Sanofi Nucleic Acid Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Sanofi Nucleic Acid Vaccine Product
Table 89. Sanofi Recent Developments/Updates
Table 90. GSK Corporation Information
Table 91. GSK Description and Business Overview
Table 92. GSK Nucleic Acid Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. GSK Nucleic Acid Vaccine Product
Table 94. GSK Recent Developments/Updates
Table 95. CNBG Corporation Information
Table 96. CNBG Description and Business Overview
Table 97. CNBG Nucleic Acid Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. CNBG Nucleic Acid Vaccine Product
Table 99. CNBG Recent Developments/Updates
Table 100. Hualan Bio Corporation Information
Table 101. Hualan Bio Description and Business Overview
Table 102. Hualan Bio Nucleic Acid Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Hualan Bio Nucleic Acid Vaccine Product
Table 104. Hualan Bio Recent Developments/Updates
Table 105. Zhifei Shengwu Corporation Information
Table 106. Zhifei Shengwu Description and Business Overview
Table 107. Zhifei Shengwu Nucleic Acid Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Zhifei Shengwu Nucleic Acid Vaccine Product
Table 109. Zhifei Shengwu Recent Developments/Updates
Table 110. Liaoning Chengda Corporation Information
Table 111. Liaoning Chengda Description and Business Overview
Table 112. Liaoning Chengda Nucleic Acid Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Liaoning Chengda Nucleic Acid Vaccine Product
Table 114. Liaoning Chengda Recent Developments/Updates
Table 115. BioKangtai Corporation Information
Table 116. BioKangtai Description and Business Overview
Table 117. BioKangtai Nucleic Acid Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. BioKangtai Nucleic Acid Vaccine Product
Table 119. BioKangtai Recent Developments/Updates
Table 120. CanSinoBIO Corporation Information
Table 121. CanSinoBIO Description and Business Overview
Table 122. CanSinoBIO Nucleic Acid Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. CanSinoBIO Nucleic Acid Vaccine Product
Table 124. CanSinoBIO Recent Developments/Updates
Table 125. Walvax Biotechnology Corporation Information
Table 126. Walvax Biotechnology Description and Business Overview
Table 127. Walvax Biotechnology Nucleic Acid Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Walvax Biotechnology Nucleic Acid Vaccine Product
Table 129. Walvax Biotechnology Recent Developments/Updates
Table 130. Fosun Pharma Corporation Information
Table 131. Fosun Pharma Description and Business Overview
Table 132. Fosun Pharma Nucleic Acid Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Fosun Pharma Nucleic Acid Vaccine Product
Table 134. Fosun Pharma Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Nucleic Acid Vaccine Distributors List
Table 138. Nucleic Acid Vaccine Customers List
Table 139. Nucleic Acid Vaccine Market Trends
Table 140. Nucleic Acid Vaccine Market Drivers
Table 141. Nucleic Acid Vaccine Market Challenges
Table 142. Nucleic Acid Vaccine Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Nucleic Acid Vaccine
Figure 2. Global Nucleic Acid Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Nucleic Acid Vaccine Market Share by Type in 2022 & 2029
Figure 4. Preventive Nucleic Acid Vaccine Product Picture
Figure 5. Therapeutic Vucleic Acid Vaccine Product Picture
Figure 6. Global Nucleic Acid Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Nucleic Acid Vaccine Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Nucleic Acid Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Nucleic Acid Vaccine Market Size (2018-2029) & (US$ Million)
Figure 13. Global Nucleic Acid Vaccine Sales (2018-2029) & (K Units)
Figure 14. Global Nucleic Acid Vaccine Average Price (US$/Unit) & (2018-2029)
Figure 15. Nucleic Acid Vaccine Report Years Considered
Figure 16. Nucleic Acid Vaccine Sales Share by Manufacturers in 2022
Figure 17. Global Nucleic Acid Vaccine Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Nucleic Acid Vaccine Players: Market Share by Revenue in 2022
Figure 19. Nucleic Acid Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Nucleic Acid Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Nucleic Acid Vaccine Sales Market Share by Country (2018-2029)
Figure 22. North America Nucleic Acid Vaccine Revenue Market Share by Country (2018-2029)
Figure 23. U.S. Nucleic Acid Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Nucleic Acid Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Nucleic Acid Vaccine Sales Market Share by Country (2018-2029)
Figure 26. Europe Nucleic Acid Vaccine Revenue Market Share by Country (2018-2029)
Figure 27. Germany Nucleic Acid Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Nucleic Acid Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Nucleic Acid Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Nucleic Acid Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Nucleic Acid Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Nucleic Acid Vaccine Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Nucleic Acid Vaccine Revenue Market Share by Region (2018-2029)
Figure 34. China Nucleic Acid Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Nucleic Acid Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Nucleic Acid Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Nucleic Acid Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Nucleic Acid Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Taiwan Nucleic Acid Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Nucleic Acid Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Nucleic Acid Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Nucleic Acid Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Philippines Nucleic Acid Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Nucleic Acid Vaccine Sales Market Share by Country (2018-2029)
Figure 45. Latin America Nucleic Acid Vaccine Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Nucleic Acid Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Nucleic Acid Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Nucleic Acid Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Nucleic Acid Vaccine Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Nucleic Acid Vaccine Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Nucleic Acid Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Nucleic Acid Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. UAE Nucleic Acid Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Nucleic Acid Vaccine by Type (2018-2029)
Figure 55. Global Revenue Market Share of Nucleic Acid Vaccine by Type (2018-2029)
Figure 56. Global Nucleic Acid Vaccine Price (US$/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of Nucleic Acid Vaccine by Application (2018-2029)
Figure 58. Global Revenue Market Share of Nucleic Acid Vaccine by Application (2018-2029)
Figure 59. Global Nucleic Acid Vaccine Price (US$/Unit) by Application (2018-2029)
Figure 60. Nucleic Acid Vaccine Value Chain
Figure 61. Nucleic Acid Vaccine Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Moderna CureVac Inovio Sanofi GSK CNBG Hualan Bio Zhifei Shengwu Liaoning Chengda BioKangtai CanSinoBIO Walvax Biotechnology Fosun Pharma